INmune Bio
INMB
INMB
36 hedge funds and large institutions have $14.5M invested in INmune Bio in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% less capital invested
Capital invested by funds: $18.2M → $14.5M (-$3.73M)
38% less call options, than puts
Call options by funds: $258K | Put options by funds: $416K
Holders
36
Holding in Top 10
–
Calls
$258K
Puts
$416K
Top Buyers
| 1 | +$384K | |
| 2 | +$259K | |
| 3 | +$223K | |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$220K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$160K |
Top Sellers
| 1 | -$256K | |
| 2 | -$182K | |
| 3 | -$175K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$75.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$70.4K |